Prescribing for Diabetes in England - 2007/08 - 2017/18 [PAS]
This is part of Prescribing for Diabetes
Official statistics- Publication Date:
- 8 Nov 2018
- Geographic Coverage:
- England
- Geographical Granularity:
- Clinical Commissioning Groups
- Date Range:
- 01 Apr 2007 to 31 Mar 2018
Summary
Published: 08 November 2018 Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2007 to March 2018.
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2007 to March 2018.
Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
Key Facts
• Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 11.4 per cent of total primary care net ingredient costs (NIC) and 4.9 per cent of prescription items (See Figure 1).
• In the financial year 2017/18 there were 53.4 million items prescribed for diabetes at a total net ingredient cost of £1,012.4 million. Up by 22.6 million prescription items and £421.7 million since 2007/08.
• Antidiabetic drugs (BNF section 6.1.2) make up 47.1 per cent of the total net ingredient cost of drugs used in diabetes and accounts for 72.6 per cent of prescription items for all diabetes prescribing.
Administrative Sources
ePACT, QOF, NDA